Project Grant HT94252510702
Award Date 8/15/25
Completion Date 8/14/28
Dollars Obligated $2.2M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
- The Defense Health Agency awarded a $3,292,001 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to produce cultured red blood cells for sickle cell disease patient support. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will run from June 1, 2025 to May 31, 2029 and aims to develop innovative...
- This Cooperative Agreement award of $638,820 from the Defense Health Agency supports an mRNA multivalent approach to develop an innovative malaria vaccine. The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to broaden the immune targets against malaria infection by including both pre-erythrocytic-stage antigens and mosquito saliva antigens. The Geneva Foundation, a non-profit research organization, will conduct this research over a 3-year period...
- This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
- The Defense Health Agency awarded a $1,074,000 Project Grant to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, for the "Production of Cultured Red Blood Cells for Sickle Cell Disease Patient Support". This grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant's period of performance...
- The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $5,072,634.00 to the Regents of the University of Minnesota for the preclinical development of MMV609, a second-generation ATP4i, for malaria. The award period runs from August 1, 2025 to July 31, 2028. This research aims to transform healthcare for military service members, veterans, and the public by advancing innovative medical solutions to address...
- This $8,042,749 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at The Ohio State University to enhance the safety and efficacy of low-titer Group O whole blood. The research involves determining optimal concentrations of hemopexin, haptoglobin, and transferrin to neutralize hemolytic byproducts during ex vivo storage of whole blood units. The project includes testing this protein...
- The Department of Defense's Defense Health Agency awarded a $393,800 Project Grant to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to conduct research on "Elucidating Mechanisms of Cell Death in Plasmodium Vivax-Infected Hepatocytes." This grant, provided through the Military Medical Research and Development program (CFDA 12.420), supports basic, translational, and clinical research aimed at developing new treatments, improving patient care, and...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...